Vergleich

Fibrinopeptide A, human

ArtNr AS-20735
Hersteller AnaSpec
CAS-Nr. 25422-31-5
Menge 1 mg
Kategorie
Typ Peptides
Format Lyophilized
Specific against other
Konjugat/Tag Unconjugated
Purity Peak Area by HPLC ≥95%
Sequence H-Ala-Asp-Ser-Gly-Glu-Gly-Asp-Phe-Leu-Ala-Glu-Gly-Gly-Gly-Val-Arg-OH
Citations Eisenberg, PR. et al. Circ. 71(5):912-918, (1985).
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias ADSGEGDFLAEGGGVR
Versandbedingung Raumtemperatur
Lieferbar
Manufacturer - Category
Catalog Peptides / Catalog Peptides Gr / Peptides
Manufacturer - Targets
Fibrinopeptide
Shipping Temperature
RT
Storage Conditions
- 20 °C
Molecular Weight
1536.7
Manufacturer - Research Area
Cardiovascular Research / Coagulation
Description
Fibrinopeptides A and B (FPA and FPB) are short amino acid sequences located at the N-terminus of fibrinogen A and B, respectively. Fibrinopeptide A is a 16-amino acid cleavage product induced by thrombin. Together with Fibrinopeptide B, it uncovers the E domain of fibrinogen. The residual protein, fibrin monomer, polymerizes to form fibrin clot. Thus, liberation of approximately 4 ng/ml of FPA per milligram of fibrinogen is closely linked to clot formation. Because proteolysis of fibrinogen accelerates early after the onset of thrombosis, marked elevations in FPA levels are expected early after the onset of clotting. Elevation of Fibrinopeptide A levels in plasma is seen in association with disorders such as disseminated intravascular coagulation, deep venous thrombosis, arterial thrombosis, and malignancy. Given the short half-life of FPA in plasma (3-5 min) and the conversion of fibrinogen to fibrin is particularly rapid and early during the course of thrombosis, measuring for elevated FPA levels in samples obtained very early after the onset of symptoms of transmural infarction would be beneficial to assess association with acute coronary thrombosis. Elevated FPA levels appear to be a marker during the course of coronary thrombosis .
Sequence One-Letter Code
ADSGEGDFLAEGGGVR
Post Synthesis Coupling
No
Usage
Research use
UNSPSC
12352202
GTIN
5400535053963

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: 1 mg
Lieferbar: In stock
lieferbar

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?
 
Schließen